See the DrugPatentWatch profile for Estradiol
What is Estradiol Valerate?
Estradiol valerate is a synthetic ester of estradiol, a naturally occurring estrogen hormone. It is a prodrug, meaning it is converted in the body into the active form, estradiol [1]. Estradiol valerate is commonly used in hormone replacement therapy (HRT) to manage symptoms associated with menopause, such as hot flashes and vaginal dryness. It is also prescribed to treat certain menstrual disorders and as part of gender-affirming hormone therapy [2].
How Does Estradiol Valerate Work?
Once administered, estradiol valerate is hydrolyzed in the body to release estradiol. Estradiol then binds to estrogen receptors, mimicking the effects of endogenous estrogen. This action helps to alleviate menopausal symptoms by restoring estrogen levels. It also plays a role in the development and maintenance of female reproductive tissues [1].
What are the Different Forms and Uses of Estradiol Valerate?
Estradiol valerate is available in various pharmaceutical forms, including oral tablets and injectable solutions [2]. Oral formulations are typically used for daily administration, while injectable forms offer longer-acting effects. Its primary uses include [2]:
* Menopause Symptom Management: Relieves hot flashes, night sweats, vaginal atrophy, and mood changes.
* Gynecological Conditions: Treats conditions like hypoestrogenism due to ovarian failure, amenorrhea, and dysfunctional uterine bleeding.
* Gender-Affirming Care: Used in feminizing hormone therapy for transgender women and non-binary individuals.
What are the Potential Side Effects of Estradiol Valerate?
Like all medications, estradiol valerate can cause side effects. Common side effects may include breast tenderness, headache, nausea, abdominal pain, and mood changes [3]. More serious, though less common, risks associated with estrogen therapy include an increased risk of blood clots, stroke, heart attack, and certain types of cancer, particularly endometrial cancer in women with an intact uterus if not used with a progestogen [2][3]. Patients should discuss their individual risk factors with a healthcare provider.
When Does the Patent for Estradiol Valerate Expire?
Information regarding the specific patent expiry dates for formulations of estradiol valerate can be complex due to various patents covering different aspects of the drug, including synthesis, formulations, and specific uses [4]. DrugPatentWatch.com provides a database that can track patent information for pharmaceuticals.
How is Estradiol Valerate Regulated?
Estradiol valerate, like other prescription medications, is regulated by health authorities such as the Food and Drug Administration (FDA) in the United States and the European Medicines Agency (EMA) in Europe. These agencies review clinical trial data to ensure the drug's safety and efficacy before approving it for marketing and monitor its post-market performance [5].
What Clinical Data Supports the Use of Estradiol Valerate?
Numerous clinical trials have evaluated the efficacy and safety of estradiol valerate for its approved indications. Studies have demonstrated its effectiveness in reducing the frequency and severity of menopausal hot flashes and improving vaginal health [1]. Research also supports its use in managing other gynecological conditions and in gender-affirming hormone therapy [2].
Can Biosimilars of Estradiol Valerate be Developed?
The development of biosimilar versions of estradiol valerate is possible, depending on the patent landscape and regulatory pathways. Biosimilars are biological products that are highly similar to an already approved biological product, with no clinically meaningful differences in safety, purity, and potency [5].
---
Sources:
[1] DrugBank
[2] National Institutes of Health (NIH)
[3] Mayo Clinic
[4] DrugPatentWatch.com
[5] U.S. Food and Drug Administration (FDA)